Luca Moscetti
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
- Advanced Breast Cancer Therapies
Papers in
- Oncology 55
- Cancer Treatment and Pharmacology 21
- HER2/EGFR in Cancer Research 15
- Colorectal Cancer Treatments and Studies 8
-
- Advanced Breast Cancer Therapies 25
- Lung Cancer Treatments and Mutations 14
- Co-authors
- Isabella Sperduti (32 shared papers)Claudia Omarini (29 shared papers)Federico Piacentini (30 shared papers)Flavia Longo (7 shared papers)Marina Chiara Garassino (4 shared papers)Gabriella Farina (4 shared papers)Eliana Rulli (4 shared papers)Mirko Marabese (3 shared papers)
In The Last Decade
Luca Moscetti
90 papers receiving 1.6k citations
Luca Moscetti's Hit Papers
Peers
Comparison fields: 5 of 75
- Oncology 830
- Pulmonary and Respiratory Medicine 701
- Cancer Research 232
- Family Practice 13
- Genetics 62
Countries citing papers authored by Luca Moscetti
This map shows the geographic impact of Luca Moscetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Moscetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Moscetti more than expected).
Fields of papers citing papers by Luca Moscetti
This network shows the impact of papers produced by Luca Moscetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Moscetti. The network helps show where Luca Moscetti may publish in the future.
Co-authors
The 25 scholars most cited alongside Luca Moscetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial Hit paper breakdown → | 2013 | 377 |
| 2 | 2014 | 90 | |
| 3 | 2011 | 79 | |
| 4 | 2005 | 78 | |
| 5 | 2021 | 65 | |
| 6 | 2023 | 61 | |
| 7 | 2018 | 57 | |
| 8 | 2006 | 52 | |
| 9 | 2014 | 43 | |
| 10 | 2015 | 41 | |
| 11 | 2015 | 40 | |
| 12 | 2012 | 36 | |
| 13 | 2013 | 34 | |
| 14 | 2015 | 31 | |
| 15 | 2014 | 27 | |
| 16 | 2014 | 23 | |
| 17 | 2018 | 21 | |
| 18 | 2019 | 20 | |
| 19 | 2017 | 20 | |
| 20 | 2001 | 20 |
About Luca Moscetti
Luca Moscetti is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Epidemiology, having authored 98 papers that have together received 1.6k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (25 papers), Cancer Treatment and Pharmacology (21 papers), Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (15 papers), Lung Cancer Treatments and Mutations (14 papers), Colorectal Cancer Treatments and Studies (8 papers), Estrogen and related hormone effects (6 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Oncology (830 citations), Pulmonary and Respiratory Medicine (701 citations), Cancer Research (232 citations), Family Practice (13 citations) and Genetics (62 citations). Luca Moscetti has collaborated with scholars based in Italy, Malaysia and Spain. Frequent co-authors include Isabella Sperduti, Claudia Omarini, Federico Piacentini, Flavia Longo, Marina Chiara Garassino, Gabriella Farina, Eliana Rulli, Mirko Marabese, Calogero Lauricella and Olga Martelli. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Clinical Breast Cancer, Journal of Cancer Research and Clinical Oncology and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.